Orthocell Ltd (OCC) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.211x

Based on the latest financial reports, Orthocell Ltd (OCC) has a cash flow conversion efficiency ratio of -0.211x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-3.07 Million ≈ $-2.17 Million USD) by net assets (AU$14.57 Million ≈ $10.31 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See OCC equity to assets ratio to measure how much of total assets are equity-financed.

Orthocell Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Orthocell Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Orthocell Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Orthocell Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Orthocell Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Prelude Therapeutics Inc NASDAQ:PRLD	-0.327x
Borosil Scientific NSE:BOROSCI	N/A
Leoch International Technology Limited F:0LT	-0.006x
Mincon Group plc IR:MIO	0.007x
Oriental Precision & Engineering Co.Ltd KQ:014940	0.088x
Amplitech Group Inc NASDAQ:AMPG	-0.065x
Hillgrove Resources Ltd AU:HGO	0.085x
Tonlin Department Store Co Ltd TW:2910	0.020x

Annual Cash Flow Conversion Efficiency for Orthocell Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Orthocell Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Orthocell Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$14.57 Million ≈ $10.31 Million	AU$-8.68 Million ≈ $-6.14 Million	-0.596x	+58.47%
2024-06-30	AU$4.53 Million ≈ $3.21 Million	AU$-6.51 Million ≈ $-4.60 Million	-1.435x	-160.48%
2023-06-30	AU$6.15 Million ≈ $4.35 Million	AU$14.59 Million ≈ $10.33 Million	2.373x	+475.40%
2022-06-30	AU$9.90 Million ≈ $7.01 Million	AU$-6.26 Million ≈ $-4.43 Million	-0.632x	-130.23%
2021-06-30	AU$16.87 Million ≈ $11.94 Million	AU$-4.63 Million ≈ $-3.28 Million	-0.275x	-9.18%
2020-06-30	AU$20.90 Million ≈ $14.79 Million	AU$-5.26 Million ≈ $-3.72 Million	-0.251x	+35.49%
2019-06-30	AU$10.72 Million ≈ $7.59 Million	AU$-4.18 Million ≈ $-2.96 Million	-0.390x	+80.09%
2018-06-30	AU$2.37 Million ≈ $1.68 Million	AU$-4.64 Million ≈ $-3.29 Million	-1.958x	-159.49%
2017-06-30	AU$4.71 Million ≈ $3.33 Million	AU$-3.56 Million ≈ $-2.52 Million	-0.754x	-10.96%
2016-06-30	AU$4.88 Million ≈ $3.46 Million	AU$-3.32 Million ≈ $-2.35 Million	-0.680x	-7.70%
2015-06-30	AU$4.38 Million ≈ $3.10 Million	AU$-2.77 Million ≈ $-1.96 Million	-0.631x	+97.26%
2014-06-30	AU$76.19K ≈ $53.91K	AU$-1.75 Million ≈ $-1.24 Million	-23.009x	-8434.14%
2013-06-30	AU$1.08 Million ≈ $762.57K	AU$-290.57K ≈ $-205.60K	-0.270x	--

About Orthocell Ltd

AU:OCC Australia Biotechnology

Market Cap

$140.14 Million

AU$198.05 Million AUD

Market Cap Rank

#17895 Global

#527 in Australia

Share Price

AU$0.73

Change (1 day)

+3.55%

52-Week Range

AU$0.71 - AU$1.53

All Time High

AU$1.75